Here are 1-3 brief analogies to describe US Physical Therapy (USPH) succinctly:

• The Starbucks of physical therapy clinics.

• The Aspen Dental for physical therapy.

• The CVS MinuteClinic model for physical therapy.

• Physical Therapy Services: Direct patient care focused on rehabilitation for musculoskeletal, neurological, and post-operative conditions, aiming to restore movement and function.
• Occupational Therapy Services: Direct patient care aimed at helping patients improve their ability to perform daily living and work activities through therapeutic interventions.
• Outpatient Clinic Management Services: Provides administrative, billing, marketing, and operational support to its network of affiliated physical and occupational therapy clinics.

US Physical Therapy (USPH) primarily sells its services directly to individuals.

The up to three categories of customers that it serves are:

1. Patients recovering from acute injuries or surgeries: This category includes individuals who have experienced sports injuries, work-related accidents, motor vehicle accidents, or are undergoing post-operative rehabilitation (e.g., after joint replacement, spinal surgery, or other orthopedic procedures).
2. Individuals managing chronic conditions or age-related functional decline: This segment comprises patients with chronic pain (such as back pain, neck pain, or fibromyalgia), arthritis, neurological disorders (e.g., stroke, Parkinson's disease, multiple sclerosis), or those experiencing age-related balance issues and decreased mobility.
3. Athletes and active individuals seeking performance enhancement or injury prevention: This category includes individuals looking to improve athletic performance, prevent future injuries, enhance flexibility and strength, or safely return to sports and activities after a period of inactivity or minor issue.

Christopher J. Reading, Chief Executive Officer and Chairman of the Board of Directors

Mr. Reading has served as Chief Executive Officer and a Director of U.S. Physical Therapy since 2004, and was appointed Chairman of the Board of Directors in May 2024. He previously held the position of President. From 1990 to 2003, Mr. Reading served in various executive and management positions with HealthSouth Corporation, where his last role was Senior Vice President of Operations, responsible for over 200 facilities across 10 states. He started his career as a clinician, graduating with a B.S. in Physical Therapy from the Medical College of Virginia in 1985. Mr. Reading also serves as President of APTQI (Alliance for Physical Therapy, Quality and Innovation).

Carey P. Hendrickson, Chief Financial Officer

Mr. Hendrickson joined U.S. Physical Therapy as Chief Financial Officer in November 2020. Prior to this, he served as Chief Financial Officer at Capital Senior Living Corporation from May 2014 to November 2020. From 2010 through 2014, he was Senior Vice President/Chief Financial Officer and Treasurer of Belo Corp., a television company. He also held various other roles at Belo Corp., including Senior Vice President/Chief Accounting Officer, Vice President/Human Resources, Vice President/Investor Relations and Corporate Communications, and Vice President/Strategic & Financial Planning. Mr. Hendrickson began his career with KPMG LLP and was the director of financial planning for Republic Financial Services before joining Belo in 1992. He holds a BBA in accounting from Baylor University and an MBA from the University of Texas at Arlington.

Eric Williams, President and Chief Operating Officer

Mr. Williams was appointed President and Chief Operating Officer in May 2024. He previously served as Chief Operating Officer for the eastern region of U.S. Physical Therapy from 2021 to 2024. Before joining USPH, he served as President and Chief Operating Officer for Omni Ophthalmic Management Consultants, and prior to that, he was Chief Operating Officer and then Chief Executive Officer of Drayer Physical Therapy Institute, LLC.

Graham Reeve, Chief Operating Officer

Mr. Reeve serves as a Chief Operating Officer for U.S. Physical Therapy.

Rick Binstein, Executive Vice President and General Counsel

Mr. Binstein holds the position of Executive Vice President and General Counsel at U.S. Physical Therapy.

• Rise of Digital Musculoskeletal (MSK) Care Platforms: Companies such as Hinge Health, SWORD Health, and Kaia Health are rapidly expanding, offering virtual and app-based physical therapy programs directly to employers and health plans. These platforms provide a convenient, often lower-cost alternative to traditional in-clinic physical therapy, potentially diverting a significant patient population, particularly for non-acute or chronic conditions, and challenging USPH's core clinic-based business model.
• Acute Shortages and Wage Inflation for Physical Therapists: The physical therapy industry is experiencing escalating shortages of qualified physical therapists and physical therapist assistants. This tight labor market drives up staffing costs and wages, USPH's largest operating expense, and creates significant challenges in recruiting and retaining staff, opening new clinics, and maintaining optimal service capacity. This trend threatens profit margins and limits growth potential.

The addressable market for U.S. Physical Therapy's main products or services in the U.S. is as follows:

• Outpatient Physical and Occupational Therapy Services: The U.S. occupational and physical therapy services market was valued at approximately USD 59.43 billion in 2024. This market is projected to grow to USD 128.17 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 10.1% during the forecast period from 2025 to 2032. Another estimate places the U.S. physical therapy services market size at USD 47.59 billion in 2024, with an expected increase to USD 61.70 billion by 2030, growing at a CAGR of 4.60% from 2025 to 2030.
• Industrial Injury Prevention Services: null

US Physical Therapy (USPH) is expected to drive future revenue growth over the next two to three years through a combination of strategic initiatives aimed at expanding its footprint, optimizing reimbursement, growing specialized services, increasing patient volumes, and leveraging technology.

1. Clinic Expansion through Acquisitions and De Novo Development: USPH consistently expands its network by acquiring existing practices and opening new "de novo" clinics. In the third quarter of 2025 alone, the company added 18 new clinics, bringing its total to 779, and reported 84 net owned clinic additions since the third quarter of 2024. This ongoing expansion directly contributes to increased patient access and overall revenue.
2. Increased Net Rate Per Patient Visit and Payer Rate Initiatives: The company has demonstrated success in enhancing its net rate per patient visit. This is achieved through favorable contract negotiations with commercial and other third-party payors, as well as an increasing proportion of higher-reimbursing workers' compensation cases in its revenue mix. Management also anticipates potential improvements in Medicare pricing in 2026, which would further boost rates. For example, the net rate per patient visit reached $105.54 in Q3 2025.
3. Growth in Industrial Injury Prevention (IIP) Services: USPH's Industrial Injury Prevention segment is a significant and consistently growing revenue stream. This segment focuses on providing services to employers for workplace injury prevention and treatment. The IIP net revenues increased by 14.6% year-over-year in Q3 2025, and this growth is often organic. In Q4 2024, IIP revenues saw an impressive 32.1% increase over the prior year.
4. Increased Patient Volume and Visits per Clinic: The company has experienced strong patient demand, leading to higher overall patient visits and a record average number of visits per clinic per day. In Q3 2025, total patient visits increased by 18% year-over-year, supported by a 2.2% increase in visits at mature clinics and hitting a record-high average of 32.2 daily patient visits per clinic. This sustained increase in patient traffic across its clinics is a fundamental driver of revenue growth.
5. Technology-Driven Efficiency and Enhanced Patient Experience: USPH is investing in technology, such as AI-powered tools for clinical documentation and a "semi-virtualized" front desk model, to streamline operations and reduce administrative burdens. While these initiatives primarily aim to mitigate labor shortages and manage costs, they also enhance patient retention and throughput, allowing clinics to serve more patients efficiently and contribute to incremental revenue, including through new cash-based programs.

Share Repurchases

• The Board of Directors authorized a share repurchase program for up to $25 million through December 31, 2026, as announced during the Q3 2025 earnings call.

Share Issuance

• Operating results per share in 2024 were impacted by an increase in the number of shares outstanding, largely due to a secondary offering completed in May 2023.
• As of November 7, 2025, the number of shares outstanding (issued less treasury stock) was 15,204,119.

Outbound Investments

• Acquisitions remain US Physical Therapy's primary capital allocation priority, consistent with its strategic growth strategy.
• In 2024, the company added 103 clinics and acquired a 75% equity interest in a three-clinic practice with $6.5 million in annual revenues.
• During the first three quarters of 2025, significant acquisitions included a 65% equity interest in a three-clinic practice generating $4.3 million in annual revenue, a 60% equity interest in another three-clinic practice generating $5.3 million in annual revenue, and an outpatient home care physical and speech therapy practice through its 50%-owned subsidiary.

Capital Expenditures

• The company's capital expenditures primarily focus on the expansion of its clinic network through the addition of new clinics and acquisitions.
• USPH added a net of 84 owned clinics since the comparable prior year period, contributing to increased physical therapy operations.
• Specific dollar values for total capital expenditures were not explicitly detailed as a distinct line item within the provided summaries; however, investment in new clinics and acquisitions drives capital deployment.